Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tack

Showing results (81-90 of 727) with videos related to

Pageof 73
Sort By:
Digestive Diseases and Sciences|May 24, 2005
The role of (duodeno)gastroesophagopharyngeal reflux in unexplained excessive throat phlegmJ Poelmans, L Feenstra, J Tack
European Journal of Clinical Investigation|July 17, 2001
Triglycerides and endothelial function in type 2 diabetesG A Rongen, C J Tack
Chemotherapy|January 1, 1985
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycinK J Tack, L D Sabath
Neurogastroenterology and Motility|June 20, 2015
Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndromeM Corsetti, F Akyuz, J Tack
The Netherlands Journal of Medicine|June 22, 2006
Thiazolidinedione derivatives in type 2 diabetes mellitusC J J Tack, P Smits
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2004
Visceral hypersensitivity in functional disorders of the upper gastrointestinal tractG Sarnelli, J Vandenberghe, J Tack
Neurogastroenterology and Motility|July 12, 2017
The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjectsF Carbone, T Vanuytsel, J Tack
Alimentary Pharmacology & Therapeutics|October 19, 2011
Pneumatic dilation for achalasia--the way forwardT Vanuytsel, G Boeckxstaens, J Tack
Diabetes Care|July 1, 1996
Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patientsC J Tack, J F Wetzels
Drug Safety|June 1, 1995
A risk-benefit assessment of cisapride in the treatment of gastrointestinal disordersJ Tack, G Coremans, J Janssens
Pageof 73

Showing results (81-90 of 727) with videos related to

Sort By:
Pageof 73
Digestive Diseases and Sciences|May 24, 2005
The role of (duodeno)gastroesophagopharyngeal reflux in unexplained excessive throat phlegmJ Poelmans, L Feenstra, J Tack
European Journal of Clinical Investigation|July 17, 2001
Triglycerides and endothelial function in type 2 diabetesG A Rongen, C J Tack
Chemotherapy|January 1, 1985
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycinK J Tack, L D Sabath
Neurogastroenterology and Motility|June 20, 2015
Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndromeM Corsetti, F Akyuz, J Tack
The Netherlands Journal of Medicine|June 22, 2006
Thiazolidinedione derivatives in type 2 diabetes mellitusC J J Tack, P Smits
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2004
Visceral hypersensitivity in functional disorders of the upper gastrointestinal tractG Sarnelli, J Vandenberghe, J Tack
Neurogastroenterology and Motility|July 12, 2017
The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjectsF Carbone, T Vanuytsel, J Tack
Alimentary Pharmacology & Therapeutics|October 19, 2011
Pneumatic dilation for achalasia--the way forwardT Vanuytsel, G Boeckxstaens, J Tack
Diabetes Care|July 1, 1996
Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patientsC J Tack, J F Wetzels
Drug Safety|June 1, 1995
A risk-benefit assessment of cisapride in the treatment of gastrointestinal disordersJ Tack, G Coremans, J Janssens
Pageof 73